Cipher Pharmaceuticals Inc is seeing a significant rise in its stock price, reflecting positive sentiment from investors.
Today, Cipher Pharmaceuticals Inc (CPH.TO) is up 2.25%, reaching a share price of CA$16.83. This increase follows a period of strong financial performance, positioning the company well in the market.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Cipher Pharmaceuticals Inc
CPH.TO
CPH.TO
Cipher Pharmaceuticals Inc
WealthAwesomeMarket cap
$417.94M
P/E
10.0x
52W high
$20.56
52W low
$12.48
1W change
+3.57%
Beta
0.48
Analyst Price Targets
Based on analyst covering CPH
Wall Street analysts forecast CPH stock price to rise 22.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$20.64
+22.6% Upside
Current Price
C$16.83
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CPH's historical volatility
30-Day Vol
19.4%
Annualized
90-Day Vol
33.3%
Annualized
Trend (90d)
-25.9%
Annualized drift
90d Mean
C$15.34
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$16.32 | C$15.26 – C$17.45 |
| 60 trading days | C$15.82 | C$14.39 – C$17.40 |
| 90 trading days | C$15.34 | C$13.66 – C$17.23 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may feel confident in Cipher's recent financial results, which indicate solid growth and profitability, likely attracting more interest in the stock.
Market Cap Reaches CA$417.94 Million
With a market cap of CA$417.94 million and a P/E ratio of 10.08, Cipher Pharmaceuticals offers an appealing valuation based on its earnings potential.
Bull case
Recent financial reports show that Cipher has significantly increased its net income and revenue, which might draw in more investors seeking growth opportunities.
Bear case
Even with this positive trend, it's wise for investors to stay cautious. Market volatility can affect stock performance, and there aren't any recent news catalysts explaining this rise.
Advertisement
Strong Financial Performance
Cipher Pharmaceuticals has shared impressive financial results in recent quarters, including a 135% increase in net income and a 51% rise in revenue. These numbers suggest that the company is effectively taking advantage of market opportunities, contributing to today's stock increase.
Market Sentiment and Investor Confidence
The uptick in Cipher's stock price likely reflects growing investor confidence, especially after their announcements of record revenue and earnings. As more investors recognize the company's strong performance, it could lead to increased buying activity, further boosting the stock's upward trend.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
